Menu

ABSTRACTS

P19 EVALUATION OF AN AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY

BJH - 2019, issue ?, february 2019

D. Gobin , C. Collard , I. Droushout , A. Demulder MD, PhD, B. Cantinieaux

Read more

P20 EVALUATION OF THE NEW KIT STA-VWF RCO (STAGO) MEASURING WILLEBRAND FACTOR ACTIVITY AND COMPARISON WITH TWO SIEMENS KITS: BC VON WILLEBRAND REAGENT AND INNOVANCE VW ACTIVITY

BJH - 2019, issue ?, february 2019

C.w. Goudji , I. Courtois , J. Yernaux , M. Blauwaert , D. Govaerts , P. Cauchie

Read more

P21 A NOVEL ADAMTS13 CONFORMATION ELISA SHOWS CONFORMATIONAL ACTIVATION OF RAT ADAMTS13 WITH EXPOSURE OF CRYPTIC EPITOPES IN VITRO

BJH - 2019, issue ?, february 2019

C. Dekimpe , L.c. VelÁsquez Pereira , J. Voorberg , H. Deckmyn PhD, S.F. De Meyer PhD, K. VanHoorelbeke PhD

Read more

P22 ANTI-CUB1 OR ANTI-SPACER ANTIBODIES THAT INCREASE ADAMTS13 ACTIVITY ACT BY ALLOSTERICALLY ENHANCING METALLOPROTEASE DOMAIN FUNCTION

BJH - 2019, issue ?, february 2019

A.-S. Schelpe , A. Petri , N. VanDePutte , H. Deckmyn PhD, S.F. De Meyer PhD, J.t.b. Crawley , K. VanHoorelbeke PhD

Read more

P23 BETRIXABAN: IMPACT ON ROUTINE AND SPECIFIC COAGULATION ASSAYS – A PRACTICAL LABORATORY GUIDE

BJH - 2019, issue ?, february 2019

R. Siriez , J. Evrard , J-M. Dogné PhD, PharmD, L. Pochet , F. Mullier PhD, PharmD, J. Douxfils PhD, PharmD

Read more

P24 IMPROVEMENT OF CHROMOGENIC ANTI-XA ASSAY TO MEASURE BETRIXABAN CONCENTRATION IN PLASMA

BJH - 2019, issue ?, february 2019

R. Siriez , J. Evrard , J-M. Dogné PhD, PharmD, L. Pochet , C. Bouvy , S. Lessire MD, PhD, F. Mullier PhD, PharmD, J. Douxfils PhD, PharmD

Read more

P25 CLOT WAVEFORM ANALYSIS: DETERMINATION OF OPTIMAL WAVELENGTH TO ASSESS THE FIBRIN COAGULATION PROCESS

BJH - 2019, issue ?, february 2019

J. Evrard , R. Siriez , L. Morimont , F. Mullier PhD, PharmD, J-M. Dogné PhD, PharmD, J. Douxfils PhD, PharmD

Read more
Top